- Home
- REKR vs APLT Comparison
REKR vs APLT Comparison
Compare REKR & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REKR
- APLT
- Stock Information
- Founded
- REKR 2017
- APLT 2016
- Country
- REKR United States
- APLT United States
- Employees
- REKR N/A
- APLT N/A
- Industry
- REKR Telecommunications Equipment
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- REKR Telecommunications
- APLT Health Care
- Exchange
- REKR Nasdaq
- APLT Nasdaq
- Market Cap
- REKR 151.6M
- APLT 178.6M
- IPO Year
- REKR N/A
- APLT 2019
- Fundamental
- Price
- REKR $1.72
- APLT $0.26
- Analyst Decision
- REKR
- APLT Buy
- Analyst Count
- REKR 0
- APLT 5
- Target Price
- REKR N/A
- APLT $4.13
- AVG Volume (30 Days)
- REKR 3.6M
- APLT 25.3M
- Earning Date
- REKR 11-13-2025
- APLT 11-13-2025
- Dividend Yield
- REKR N/A
- APLT N/A
- EPS Growth
- REKR N/A
- APLT N/A
- EPS
- REKR N/A
- APLT N/A
- Revenue
- REKR $49,028,000.00
- APLT $1,000,000.00
- Revenue This Year
- REKR $10.03
- APLT N/A
- Revenue Next Year
- REKR $24.80
- APLT $5,935.35
- P/E Ratio
- REKR N/A
- APLT N/A
- Revenue Growth
- REKR 11.89
- APLT N/A
- 52 Week Low
- REKR $0.62
- APLT $0.22
- 52 Week High
- REKR $3.42
- APLT $10.48
- Technical
- Relative Strength Index (RSI)
- REKR 34.77
- APLT 28.24
- Support Level
- REKR $1.63
- APLT $0.25
- Resistance Level
- REKR $2.04
- APLT $0.40
- Average True Range (ATR)
- REKR 0.18
- APLT 0.10
- MACD
- REKR -0.06
- APLT -0.04
- Stochastic Oscillator
- REKR 11.16
- APLT 5.13
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.